KTE-C19-104: A Phase 1/2 Multi-Center Study Evaluating the Safety and Efficacy of KTE-C19 in Pediatric and Adolescent Subjects with Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (r/r ALL) (ZUMA-4)

  • Hijiya, Nobuko (PD/PI)

Project: Research project

Project Details

StatusActive
Effective start/end date8/1/16 → 8/31/50

Funding

  • Kite Pharma, Inc.